Genscript Biotech Investor Relations Material
Latest events
H2 2024
Genscript Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genscript Biotech Corporation
Access all reports
GenScript Biotech Corporation is a China-based biotechnology company specializing in life sciences services and products. The company provides a wide range of solutions, including gene synthesis, peptide synthesis, antibody development, and protein engineering. GenScript serves customers in sectors such as pharmaceuticals, agriculture, and industrial biotechnology. The company is headquartered in Nanjing, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Genscript Biotech Corporation
H1 2024
Genscript Biotech Corporation
H2 2024
Genscript Biotech Corporation
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
1548
Country
🇭🇰 Hong Kong